bromfenac has been researched along with Diabetic Retinopathy in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Babazono, T; Endo, N; Hirose, A; Kitano, S; Ogihara, R; Takeda, R; Tobimatsu, Y | 1 |
Elbarawy, AA; Gabr, AF; Kamel, MF | 1 |
Baek, SK; Lee, MW; Lee, YH; Song, SH | 1 |
Amon, M; Findl, O; Goslings, WRO; Henry, YP; Joosse, MV; Kohnen, T; Murta, JCN; Nagy, ZZ; Nuijts, RMMA; Rulo, AHF; Schouten, JSAG; Tassignon, MJ; van den Biggelaar, FJHM; Veldhuizen, CA; Wielders, LHP; Winkens, B | 1 |
Blasetti, F; Boscia, F; Pinna, A; Ricci, GD | 1 |
Endo, N; Haruyama, K; Kato, S; Kitano, S; Shoji, M | 1 |
4 trial(s) available for bromfenac and Diabetic Retinopathy
Article | Year |
---|---|
Comparison of the Effect of Bromfenac versus Betamethasone Ophthalmic Solutions in Patients with Diabetic Macular Edema.
Topics: Aged; Betamethasone; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Middle Aged; Ophthalmic Solutions; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome | 2023 |
Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema.
Topics: Angiogenesis Inhibitors; Diabetes Mellitus; Diabetic Retinopathy; Humans; Intravitreal Injections; Macular Edema; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome | 2023 |
Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bevacizumab; Bromobenzenes; Dexamethasone; Diabetic Retinopathy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intraocular; Intravitreal Injections; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Uveitis, Anterior; Visual Acuity | 2010 |
2 other study(ies) available for bromfenac and Diabetic Retinopathy
Article | Year |
---|---|
Effect of 0.1% Bromfenac for Preventing Macular Edema after Cataract Surgery in Patients with Diabetes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extraction; Diabetic Retinopathy; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Postoperative Period; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2020 |
Bromfenac eyedrops in the treatment of diabetic macular edema: a pilot study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Diabetic Retinopathy; Female; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Pilot Projects; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2017 |